These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34688987)

  • 1. Therapeutic supramolecular tubustecan hydrogel combined with checkpoint inhibitor elicits immunity to combat cancer.
    Wang F; Su H; Xu D; Monroe MK; Anderson CF; Zhang W; Oh R; Wang Z; Sun X; Wang H; Wan F; Cui H
    Biomaterials; 2021 Dec; 279():121182. PubMed ID: 34688987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker-based immunotherapy.
    Wang F; Xu D; Su H; Zhang W; Sun X; Monroe MK; Chakroun RW; Wang Z; Dai W; Oh R; Wang H; Fan Q; Wan F; Cui H
    Sci Adv; 2020 May; 6(18):eaaz8985. PubMed ID: 32490201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
    Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
    Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment.
    Gu J; Zhao G; Yu J; Xu P; Yan J; Jin Z; Chen S; Wang Y; Zhang LW; Wang Y
    J Nanobiotechnology; 2022 Aug; 20(1):372. PubMed ID: 35953828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orchestrated metal-coordinated carrier-free celastrol hydrogel intensifies T cell activation and regulates response to immune checkpoint blockade for synergistic chemo-immunotherapy.
    Wu L; Pi W; Huang X; Yang L; Zhang X; Lu J; Yao S; Lin X; Tan X; Wang Z; Wang P
    Biomaterials; 2025 Jan; 312():122723. PubMed ID: 39121732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecular Filament Hydrogel as a Universal Immunomodulator Carrier for Immunotherapy Combinations.
    Wang F; Su H; Wang Z; Anderson CF; Sun X; Wang H; Laffont P; Hanes J; Cui H
    ACS Nano; 2023 Jun; 17(11):10651-10664. PubMed ID: 37212741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioadhesive injectable hydrogel with phenolic carbon quantum dot supported Pd single atom nanozymes as a localized immunomodulation niche for cancer catalytic immunotherapy.
    He H; Fei Z; Guo T; Hou Y; Li D; Wang K; Ren F; Fan K; Zhou D; Xie C; Wang C; Lu X
    Biomaterials; 2022 Jan; 280():121272. PubMed ID: 34864428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable Supramolecular Hydrogel for Locoregional Immune Checkpoint Blockade and Enhanced Cancer Chemo-Immunotherapy.
    Liu M; Cao Z; Zhang R; Chen Y; Yang X
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33874-33884. PubMed ID: 34275267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable hydrogels for personalized cancer immunotherapies.
    Mohaghegh N; Ahari A; Zehtabi F; Buttles C; Davani S; Hoang H; Tseng K; Zamanian B; Khosravi S; Daniali A; Kouchehbaghi NH; Thomas I; Serati Nouri H; Khorsandi D; Abbasgholizadeh R; Akbari M; Patil R; Kang H; Jucaud V; Khademhosseini A; Hassani Najafabadi A
    Acta Biomater; 2023 Dec; 172():67-91. PubMed ID: 37806376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Han X; Li H; Zhou D; Chen Z; Gu Z
    Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ chemoimmunotherapy hydrogel elicits immunogenic cell death and evokes efficient antitumor immune response.
    Liu Q; Xu R; Shen J; Tao Y; Shao J; Ke Y; Liu B
    J Transl Med; 2024 Apr; 22(1):341. PubMed ID: 38594751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supramolecular Tubustecan Hydrogel as Chemotherapeutic Carrier to Improve Tumor Penetration and Local Treatment Efficacy.
    Wang F; Su H; Lin R; Chakroun RW; Monroe MK; Wang Z; Porter M; Cui H
    ACS Nano; 2020 Aug; 14(8):10083-10094. PubMed ID: 32806082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable Micelle-Incorporated Hydrogels for the Localized Chemo-Immunotherapy of Breast Tumors.
    Qin X; He L; Feng C; Fan D; Liang W; Wang Q; Fang J
    ACS Appl Mater Interfaces; 2021 Oct; 13(39):46270-46281. PubMed ID: 34550685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable Anti-inflammatory Nanofiber Hydrogel to Achieve Systemic Immunotherapy Post Local Administration.
    Chen M; Tan Y; Dong Z; Lu J; Han X; Jin Q; Zhu W; Shen J; Cheng L; Liu Z; Chen Q
    Nano Lett; 2020 Sep; 20(9):6763-6773. PubMed ID: 32787149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-2 Responsive Peptide Hydrogel-Based Nanoplatform for Multimodal Tumor Therapy.
    Zhang Q; Hu W; Guo M; Zhang X; Zhang Q; Peng F; Yan L; Hu Z; Tangthianchaichana J; Shen Y; Hu H; Du S; Lu Y
    Int J Nanomedicine; 2024; 19():53-71. PubMed ID: 38187906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor lysates-constructed hydrogel to potentiate tumor immunotherapy.
    Chen X; Jiang Z; Lin Y; Yu C; Nie X; Xu G; Xu W; Jiang Y; Luan Y
    J Control Release; 2023 Jun; 358():345-357. PubMed ID: 37150404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment.
    Cheng Z; Xue C; Liu M; Cheng Z; Tian G; Li M; Xue R; Yao X; Zhang Y; Luo Z
    Acta Biomater; 2023 Oct; 169():289-305. PubMed ID: 37544392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programming Injectable DNA Hydrogels Yields Tumor Microenvironment-Activatable and Immune-Instructive Depots for Augmented Chemo-Immunotherapy.
    Fan Y; Zhan M; Liang J; Yang X; Zhang B; Shi X; Hu Y
    Adv Sci (Weinh); 2023 Oct; 10(29):e2302119. PubMed ID: 37541435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogel/nanoparticles-mediated cooperative combination of antiangiogenesis and immunotherapy.
    Yang A; Sheng S; Bai Y; Xing G; Yu X; Zhu D; Mei L; Dong X; Lv F
    Acta Biomater; 2022 Nov; 153():124-138. PubMed ID: 36179979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.